Adaptive programming improves outcomes in drug court: an experimental trial

Prior studies in drug courts have reported improved outcomes when participants were matched to schedules of judicial status hearings based on their criminological risk level. The current experiment determined whether incremental efficacy could be gained by periodically adjusting the schedule of stat...

Descripción completa

Guardado en:  
Detalles Bibliográficos
Autores principales: Marlowe, Douglas B. (Autor) ; Festinger, David S. (Autor) ; Dugosh, Karen L. (Autor) ; Benasutti, Kathleen M. (Autor) ; Fox, Gloria (Autor) ; Croft, Jason R. (Autor)
Tipo de documento: Electrónico Artículo
Lenguaje:Inglés
Publicado: 2012
En: Criminal justice and behavior
Año: 2012, Volumen: 39, Número: 4, Páginas: 514-532
Acceso en línea: Presumably Free Access
Volltext (lizenzpflichtig)
Journals Online & Print:
Gargar...
Verificar disponibilidad: HBZ Gateway
Palabras clave:
Descripción
Sumario:Prior studies in drug courts have reported improved outcomes when participants were matched to schedules of judicial status hearings based on their criminological risk level. The current experiment determined whether incremental efficacy could be gained by periodically adjusting the schedule of status hearings and clinical case management sessions in response to participants? ensuing performance in the program. The adjustments were made pursuant to a priori criteria specified in an adaptive algorithm. Results confirmed that participants in the full adaptive condition (n = 62) were more than twice as likely as those assigned to baseline matching only (n = 63) to be drug abstinent during the first 18 weeks of the program; however, graduation rates and the average time to case resolution were not significantly different. The positive effects of the adaptive program appear to have stemmed from holding noncompliant participants more accountable for meeting their attendance obligations in the program. Directions for future research and practice implications are discussed.
ISSN:1552-3594
DOI:10.1177/0093854811432525